Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. [electronic resource]
Producer: 20151221Description: 394-410 p. digitalISSN:- 1757-4684
- Atrial Fibrillation -- drug therapy
- Drug Delivery Systems -- methods
- Drug Evaluation, Preclinical -- methods
- G Protein-Coupled Inwardly-Rectifying Potassium Channels -- antagonists & inhibitors
- Gene Expression
- Heart Atria -- metabolism
- Humans
- Kv1.5 Potassium Channel -- antagonists & inhibitors
- Models, Biological
- Myocytes, Cardiac -- metabolism
- Pluripotent Stem Cells -- metabolism
- Potassium Channel Blockers -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.